Thanks for your interest in Peregrine and the upcoming AACR Annual Meeting. The antibody used in Dr Thorpe's abstract below is a mouse version of one of Peregrine's PS-targeting antibodies.
Best Regards, Jay
Jay Carlson | Manager, Investor Relations
Peregrine Pharmaceuticals, Inc. 14282 Franklin Avenue - Tustin, Ca - 92780 Tel: +1.714.508.6042 | Corporate: +1.714.508.6000 | Fax: +1.714.838.9433 jcarlson@peregrineinc.com<mailto:jcarlson@peregrineinc.com> | http://www.peregrineinc.com<http://www.peregrineinc.com/>
Is Peregrine a part of this or is Dr. Thorpe collaborating outside of Peregrine?
Presentation Title: Cure of castration-resistant prostate cancer in TRAMP mice by reactivating tumor immunity with a phosphatidylserine-targeting antibody Presentation Time: Tuesday, Apr 03, 2012, 1:00 PM - 5:00 PM Location: McCormick Place West (Hall F), Poster Section 19 Poster Board Number: 12 Author Block: Yi Yin, Xianming Huang, Gustavo Barbero, Dan Ye, Philip E. Thorpe. UT Southwestern Medical Ctr., Dallas, TX